Scl 70 Scl 70 Scl 70 ACA ACA ACA RNAPIII RNAPIII RNAPIII
positive n=41 negative n=59
p
positive n=27 negative n=73
p
positive n=15 negative n=85
p
lcSSc 15 (36.6%) 48 (81.4%) <0.001 27 (100%) 36 (49.3%) <0.001 5 (33.3%) 58 (68.2%) 0.027
Female 38 (92.7%) 49 (83.1%) 0.229 26 (96.3) 61 (83.6%) 0.177 11 (73.3%) 76 (89.4%) 0.103
ILD 24 (58.5) 9 (15.3%) <0.001 1 (3.7%) 32 (43.8%) <0.001 9 (60%) 24 (28.2%) 0.016
PAH 1 (2.4%) 2 (3.4%) 1.000 0 3 (4.1%) 0.561 2 (13.3%) 1 (1.2%) 0.058
Malignancy 0 3 (5.1%) 0.267 0 3 (4.1%) 0.561 2 (13.3%) 1 (1.2%) 0.058
DU 4 (9.8%) 9 (15.3%) 0.551 4 (14.8%) 9 (12.3%) 0.743 2 (13.3%) 11 (12.9%) 1.000
GIS 24 (58.5%) 36 (61%) 0.803 15 (55.6%) 45 (61.6%) 0.581 11 (73.3%) 49 (57.6%) 0.392
Overlap 5 (12.2%) 19 (32.2%) 0.021 11 (40.7) 13 (17.8%) 0.017 1 (6.7%) 23 (27.1%) 0.110
Age 46.9±12.7 51±11.8 0.210 50.4±10.3 48.4±12.9 0.602 55.3±8.5 47.7±12.5 0.026
Disease duration 2.03±1.5 2.14±1.3 0.471 2±1.4 2.13±1.4 0.770 2.6±1.6 2±1.3 0.162
mRSS 14.3±11.5 8.6±9 0.002 6.5±5.2 12.5±11.4 0.024 20.4±13.8 9.2±8.6 0.001